GENE ONLINE|News &
Opinion
Blog

JAK Inhibitor
Licensing JAK Inhibitor
Biohaven Licenses TYK2/JAK1 Dual Inhibitor From China’s Highlight In $970 Million Pact
2023-03-23
M&A Oncology
GSK to Acquire Biopharmaceutical Company Sierra Oncology for $1.9B
2022-04-17
Technology HUMIRA
The Next SuperStar Drug? AbbVie Places its Hope on Skyrizi and Rinvoq
2022-02-16
Trials & Approvals FDA Approval
FDA Approves Incyte’s Jakafi for Chronic Graft-Versus-Host Disease
2021-09-23
Trials & Approvals Atopic Dermatitis
Pfizer’s JAK1 Inhibitor Impresses in Phase 3 Atopic Dermatitis Trial
2020-11-12
Trials & Approvals Atopic Dermatitis
Pfizer Announces Positive Top-Line Results for JAK Inhibitor in Ankylosing Spondylitis Trial
2020-11-08
Trials & Approvals Alopecia Areata
Lilly, Incyte Gaining Ground in the Fight against Alopecia Areata
2020-11-01
Japan
Torii Pharma’s Corectim Ointment Features in Japan’s NHI Drug Price List
2020-04-26
Trials & Approvals IL-31
Pfizer’s Dupixent Rival Meets Endpoints in Atopic Dermatitis Trial
2020-04-05
LATEST
Bio Asia Pacific 2024 Close ASEAN Collaborations: Catalyzing Innovation and Global Partnerships
2024-09-12
Illumina’s IVD Biomarker Test Becomes the First FDA-approved Pan-cancer Companion Diagnostics Kit
2024-09-11
Lotus Pharma Expands in Southeast Asia with Alpha Choay Acquisition from Sanofi
2024-09-06
Indian CDMO Stocks in the Spotlight: US House to Vote on BIOSECURE Act Next Week
2024-09-06
Eli Lilly Joins Forces with AI Startup Genetic Leap in $409M Deal Centered Around RNA-Targeted Drug Discovery
2024-09-06
Illumina Wins EU Court Battle, Dodges Fine, but Grail Deal Already Void
2024-09-05
Breaking New Ground for Clinical Trials with AI/ML Applications
2024-09-05
READ MORE
EVENT
2024-09-13
ESMO Congress 2024
Barcelona, Spain
2024-10-09
Medical Japan 2024 Tokyo
Tokyo, Japan
2024-10-10
BioJapan / Regenerative Medicine Japan / healthTECH JAPAN 2024
Tokyo, Japan
2024-10-15
BIO Investor Forum 2024
San Francisco, U.S.A.
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top